Cargando…
Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms
At the end of 2019, the entire world has witnessed the birth of a new member of coronavirus family in Wuhan, China. Ever since, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has swiftly invaded every corner on the planet. By the end of April 2020, almost 3.5 million cases have bee...
Autores principales: | El-Ghiaty, Mahmoud A., Shoieb, Sherif M., El-Kadi, Ayman O.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318945/ https://www.ncbi.nlm.nih.gov/pubmed/32758877 http://dx.doi.org/10.1016/j.mehy.2020.110033 |
Ejemplares similares
-
Arsenic: Various species with different effects on cytochrome P450 regulation in humans
por: El-Ghiaty, Mahmoud A., et al.
Publicado: (2021) -
Targeting arachidonic acid–related metabolites in COVID-19 patients: potential use of drug-loaded nanoparticles
por: Shoieb, Sherif M., et al.
Publicado: (2020) -
Methylmercury (MeHg) transcriptionally regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) in Hepa-1c1c7 cells
por: Alqahtani, Mohammed A., et al.
Publicado: (2023) -
Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic Target
por: Elshenawy, Osama H., et al.
Publicado: (2017) -
Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites
por: Shoieb, Sherif M., et al.
Publicado: (2020)